Corvus Pharmaceuticals, Inc. (CRVS) Social Stream
CORVUS PHARMACEUTICALS INC (CRVS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CRVS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 4 | $6 | $3.5 | $5.125 | $3.45 | 48.55% |
| 2021-12-01 | 5 | $8 | $3.5 | $5.7 | $3.45 | 65.22% |
| 2021-12-03 | 4 | $8 | $3.5 | $6.375 | $3.45 | 84.78% |
| 2022-05-11 | 3 | $8 | $3.5 | $6.375 | $3.45 | 84.78% |
| 2022-08-09 | 3 | $8 | $4 | $6 | $3.45 | 73.91% |
| 2022-10-07 | 4 | $8 | $2 | $5.333 | $3.45 | 54.58% |
| 2022-11-07 | 4 | $6 | $2 | $3.333 | $3.45 | -3.39% |
| 2022-12-14 | 3 | $3 | $2 | $2.5 | $3.45 | -27.54% |
| 2023-04-05 | 4 | $3.5 | $2 | $2.833 | $3.45 | -17.88% |
| 2023-05-09 | 4 | $4 | $3.5 | $3.833 | $3.45 | 11.1% |
| 2023-05-29 | 4 | $8 | $3.5 | $4.875 | $3.45 | 41.3% |
| 2023-05-30 | 4 | $10 | $3.5 | $6.375 | $3.45 | 84.78% |
The Trend in the Analyst Price Target
Over the past 19 months, CRVS's average price target has gone up $1.25.
CRVS reports an average of 299.02% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-09 | 3 | 8 | 4 | 6.000 | 0.870 | 589.66% |
| 2022-10-07 | 4 | 8 | 2 | 5.333 | 0.940 | 467.34% |
| 2022-11-07 | 4 | 6 | 2 | 3.333 | 0.849 | 292.58% |
| 2022-11-07 | 4 | 8 | 2 | 4.500 | 0.849 | 430.04% |
| 2022-11-07 | 3 | 8 | 2 | 4.500 | 0.849 | 430.04% |
CRVS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
CRVS's average broker recommendation rating improved by 0 over the prior 17 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how CORVUS PHARMACEUTICALS INC fares relative to all US stocks, note that its average analyst price target is higher than 101.15% of that group.
- To contextualize these metrics, consider that out of all US stocks, CORVUS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 307.1% of them.
- In terms of how CORVUS PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -1385.23% of that group.
- CRVS has a greater upside potential (average analyst target price relative to current price) than 651.64% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, RLMD, PDSB, and EPIX are the three stocks most similar to CORVUS PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding CRVS using the data that counts. Try POWR Ratings for free.